Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance

Keyphrases

• Natural History 100%
• Lymphangioleiomyomatosis 100%
• Angiomyolipoma 100%
• Sporadic LAM 63%
• Tumor Size 18%
• Continuous Monitoring 9%
• AIMS™ 9%
• Clinical Practice Guidelines 9%
• Clinical Features 9%
• Nottingham 9%
• High Prevalence 9%
• Lung Disease 9%
• Lung 9%
• Demographic Data 9%
• Rare Diseases 9%
• Bleeding 9%
• Tumor 9%
• Kidney 9%
• Lung Function 9%
• European Respiratory Society 9%
• Working Diagnosis 9%
• Bleeding Risk 9%
• MRI Scan 9%
• National Cohort 9%
• Clinical Records 9%
• Benign Tumor 9%
• Tumor Screening 9%
• Nephrectomy 9%
• Lung Tumor 9%
• Lymphatic Abnormalities 9%
• National Center 9%
• Tumor Surveillance 9%
• Surveillance Protocol 9%
• Tuberous Sclerosis Complex 9%
• Screening Protocol 9%
• Lung Cysts 9%

Medicine and Dentistry

• Lymphangioleiomyomatosis 100%
• Angiomyolipoma 100%
• Neoplasm 36%
• Bleeding 18%
• Disease 9%
• Prevalence 9%
• Clinical Feature 9%
• Symptom 9%
• Silo-Filler's Disease 9%
• Magnetic Resonance Imaging 9%
• Rare Disease 9%
• Tuberous Sclerosis 9%
• Nephrectomy 9%
• Benign Tumor 9%
• Lymphatic Disease 9%
• Bronchogenic Cyst 9%